Revenue: The sum of all revenue fields included for a company's operating activities.
Interpace Biosciences, Inc. (IDXG) had Revenue of $9.03M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$9.03M |
$0.72M |
|
$3.13M |
|
$5.90M |
|
$7.91M |
|
$1.12M |
|
$0.01M |
|
$1.13M |
|
$1.13M |
|
$0.83M |
|
$0.83M |
|
$0.72M |
|
$0.83M |
|
$1.12M |
|
$1.35M |
|
22.79M |
|
27.71M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$9.96M |
|
$1.31M |
|
$23.45M |
|
$33.41M |
|
$3.96M |
|
-- |
|
$6.37M |
|
$10.33M |
|
$23.08M |
|
$23.08M |
|
$23.08M |
|
27.70M |
|
| Cash Flow Statement Financials | |
$0.28M |
|
$-0.14M |
|
-- |
|
$2.50M |
|
$2.65M |
|
$0.14M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
65.37% |
|
12.43% |
|
12.43% |
|
-- |
|
12.54% |
|
7.98% |
|
$0.14M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
-- |
|
1.52 |
|
59.04 |
|
3.60% |
|
3.60% |
|
2.49% |
|
3.60% |
|
$0.83 |
|
$0.01 |
|
$0.01 |
|